创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

TAO Yucen, XU Shujing, ZHANG Xujie, LIU Xinyong, ZHAN Peng. Research Advances in Drug Discovery Based on Miniaturized Synthesis[J]. Progress in Pharmaceutical Sciences, 2022, 46(1): 19-32.
Citation: TAO Yucen, XU Shujing, ZHANG Xujie, LIU Xinyong, ZHAN Peng. Research Advances in Drug Discovery Based on Miniaturized Synthesis[J]. Progress in Pharmaceutical Sciences, 2022, 46(1): 19-32.

Research Advances in Drug Discovery Based on Miniaturized Synthesis

  • In modern discovery of innovative drugs, the quality of compound library directly affects the success of the whole process of research and development. Thus, how to quickly construct a high-quality library of compounds large in number and rich in structural diversity is a key step in drug discovery. With the rapid development of miniaturized (microscale/nanoscale) synthetic technology and biological screening technology, the goal of constructing multiple high quality compound libraries in a short time has been gradually realized, new hit and lead compounds being constantly discovered. Based on the relevant research in recent years, the latest progress in drug discovery through nanoscale synthesis is summarized, aiming to provide new insights to drug discovery based on miniaturized synthesis.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return